chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 21-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 29-SEP-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored dose of oral, ROTATEQ (Lot#L008996, exp.date 01-DEC-2016; Lot#L008054, exp.date 30-NOV-2016; Lot #K019370, exp.date 16-JUL-2016) (Strength, dose and frequency were not provided). Concomitant medication was not reported. This is one of several reports from same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired product administered, No adverse event
Clinical narrative: This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 21-APR-2015 (also reported as 21-APR-2013), the patient was inadvertently vaccinated with an expired dose of ZOSTAVAX (dose, route and lot # were not reported, expiration date: 13-MAR-2015). No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: HPV9
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (Lot # L013429 exp.date 27-JUL-2017; Lot# L004014 exp.date 04-MAR-2017) (Strength, dose, route and frequency were not provided). Concomitant medication was not reported. No adverse effects reported. This is one of several reports from same source. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (Lot#L018501, exp. date 22-JUN-2017; Lot#L016427, exp. date 13-APR-2017; Lot#L004754, exp. date 10-NOV-2016) (Strength, dose, route and frequency were not provided). Concomitant medication was not reported. No adverse effects reported. This is one of several reports from same source. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to unspecified patients of unknown age and gender. The patient's medical history and current conditions were not provided. On an unknown dates, the patient were vaccinated with a doses of improperly stored GARDASIL (dose and route were not reported) lot # K010215, expiration date 05-MAY-2017. No adverse effects have been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. The healthcare worker reported that since 11-DEC-2015, the patients had been vaccinated with unspecified doses of oral, ROTATEQ (Lot# L013193, exp. date 20-JAN-2017) (Strength and route were not provided), which were exposed to temperatures outside of the recommended range. Concomitant medication was not reported. No adverse experience had been reported. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medication and drug reactions or allergies were reported. On unknown dates, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot # L021211, expiration date 10-JUN-2017; Lot026408, expiration date 15-JUL-2017; L016127, expiration date 06-MAY-2017; L019124, expiration date 27-MAY-2017)(strength, dose and route of administration were not provided). The doses were exposed to temperatures outside of the recommended range (warmer temperature) before the vaccination. No adverse experience was reported. Additional information has been requested.
Age: 31.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody positive, Mumps antibody test positive, Rubella antibody negative
Clinical narrative: This spontaneous report as received from a healthcare worker refers to a currently (at the time of the report) 31 years old male patient. The patient's medical history and current conditions were not provided. On an unknown date (reported as "childhood"), the patient was vaccinated with a dose of M-M-R II (lot #, expiration date, dose and route were not reported). Secondary suspects and concomitant therapies were not reported. On an unknown date, the patient underwent a laboratory test which showed positive titers for mumps and measles but negative titers for rubella. The outcome of rubella titers negative was unknown. The relatedness between adverse event and M-M-R II was not reported. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a licensed vocational nurse and refers to a 4 year old male patient. No information regarding the patient's medical history and concomitant medications was reported. On 03-SEP-2015 at 10:07 am, the patient was vaccinated with an improperly stored dose (it was the patient's second dose; reported as #1 given else) of PROQUAD (Merck) lot # K008185, expiration date 05-DEC-2015, subcutaneous in the right thigh (strength and dose were not provided). Concomitant vaccination included the first dose of KINRIX lot # reported as S4L2R, intramuscular in the left thigh (given on the same time as the suspect vaccine). There was no illness at the time of vaccination. No adverse effects were reported. The patient was vaccinated at public health clinic/hospital and the vaccine was purchased with public funds. This is one of the several reports received from the same source. Additional information is not expected as all correspondence was received.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of VAQTA (Lot#K012457, exp. date 04-JUN-2017; Lot#K019560, exp. date 02-JUN-2017; Lot#L007559, exp. date 01-JUN-2017; Lot#L018499, exp. date 25-FEB-2017) (Strength, dose, route and frequency were not provided). Concomitant medication was not reported. No adverse effects reported. This is one of several reports from same source. Additional information has been requested.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. The healthcare worker reported that since 11-DEC-2015, the patients had been vaccinated with unspecified doses of PEDVAXHIB (lot # L014429, Exp date 15-MAR-2018 (Strength and route were not provided), which were exposed to temperatures outside of the commended range. Concomitant medication was not reported. No adverse experience had been reported. This is one of several reports from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a Nurse refers to a patient of unknown age and gender. Since 01-OCT-2015, the patients were vaccinated with GARDASIL (dose, frequency, route of administration and indication were not reported; lot# K008931 expiration date: 04-MAR-2017, L020162 expiration date: 23-JUL-2017, K006117 expiration date: 14-JAN-2017), which were exposed to temperatures outside of the recommended range. No adverse experiences was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a licensed vocational nurse and refers to a 5 year old male patient. No information regarding the patient's medical history and concomitant medications was reported. On 11-SEP-2015 at 09_58 am, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) lot # K009891, expiration date 11-JAN-2016, subcutaneous in the right thigh (strength and dose were not provided). Concomitant vaccination included the first dose of KINRIX lot # reported as S4L2R, intramuscular in the left thigh. There was no illness at the time of vaccination. No adverse effects were reported. The patient was vaccinated at public health clinic/hospital and the vaccine was purchased with public funds. This is one of the several reports received from the same source. Additional information is not expected as all correspondence was received.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. The patients' medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with a doses of PEDVAXHIB lot # L012837, expiration date 11-MAR-2018, which were exposed to temperatures outside of the recommended range. No adverse experience has been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Age: 77.0
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a pharmacy student refers to a 77 year old male patient. The patient's pertinent medical history, drug reactions and allergies were not reported. On 24-NOV-2015, the patient was vaccinated with 0.5 ml dose of (Oka/Merck) VARIVAX injection, lot # K003411, expiry date 06-MAR-2016, subcutaneously instead of ZOSTAVAX. No concomitant therapies were reported. No adverse effects were reported. Additional information is not expected as the reporter did not wish to be contacted.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 06-OCT-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8  F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. The patients' medical history and current conditions were not provided. In approximately 2015 (reported as "since 17-SEP-2015"), the patient were vaccinated with a doses of MMRII lot # L002873, expiration date 27-JAN-2017, which were exposed to temperatures outside of the recommended range. No adverse experience has been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HPV9
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified patients of unknown age and gender. The patients' medical history and current conditions were not provided. On an unknown dates, the patients were vaccinated with a doses of GARDASIL 9 lot # L007560, expiration date 15-JUN-2017, which were exposed to temperatures outside of the recommended range. No adverse experience has been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 08-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 07-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 27-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 29-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 28-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 26-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # K024036 exp date 26-NOV-2016) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 01-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports received from the same source. Additional information is not expected as all follow up information to complete the case was received.
Age: 48.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Pain, Pyrexia, Swelling
Clinical narrative: Information has been received from a physician via a field representative concerning a 48 year old female patient. The patient's medical history and concurrent condition were not provided. On 11-DEC-2015 the patient was vaccinated with PNEUMOVAX 23 (lot #, expiration date, dose and route unspecified). Concomitant therapy was not provided. On 11-DEC-2015, the patient had a "horrendous" reaction at the injection site after receiving PNEUMOVAX 23. Unspecified steroids and antibiotics were given for the event. The outcome of the event was unknown. The causality of the event and PNEUMOVAX was not provided. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a physician via a field representative concerning a 48 year old female patient. The patient's medical history and concurrent condition were not provided. On 11-DEC-2015 the patient was vaccinated with PNEUMOVAX 23 (lot #, expiration date, dose and route unspecified). Concomitant therapy was not provided. On 11-DEC-2015, the patient had a "horrendous" reaction at the injection site after receiving PNEUMOVAX 23. Unspecified steroids and antibiotics were given for the event. The outcome of the event was unknown. The causality of the event and PNEUMOVAX was not provided. Additional information has been requested.
Age: 55.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Pain in extremity
Clinical narrative: Arm severe pain stabbing burning arm hurts to use medrol dose.
Age: 58.0
Sex: F
Vaccine: FLUX
Symptoms: Activities of daily living impaired, Drug administered at inappropriate site, Pain in extremity
Clinical narrative: My arm start hurting and aching so much so I had to stop what I was doing and come home. The shot was given high up on my arm and hurt like no other shot I've every received.
Age: 32.0
Sex: M
Vaccine: JEVX
Symptoms: Hypoaesthesia
Clinical narrative: Left ear and skin around it has been numb since that day.
Age: 92.0
Sex: F
Vaccine: FLU4
Symptoms: Dyspnoea, Echocardiogram, Myocardial infarction, Pneumonia, X-ray
Clinical narrative: Shortness of breath, called 911, admitted to hospital. Put on breathing mask, had heart attack.
Age: 6.0
Sex: M
Vaccine: 6VAX-F
Symptoms: Diarrhoea, Headache, Pyrexia
Clinical narrative: High fever approx 100, giving Tylenol 6 hourly and continued for 2 days, today 12/20/2015 my son complained about headache on and off and diarrhea. Continuing Tylenol for fever and pains.
Age: 22.0
Sex: M
Vaccine: FLUN4
Symptoms: Abdominal X-ray, Abdominal pain, Colonoscopy normal, Computerised tomogram abnormal, Crohn's disease
Clinical narrative: Gradual onset of abdominal pain, nausea, vomiting and congestion.  Sept 2014 abdominal xrays (2) and ultrasound were normal. Labs normal. Symptoms progressed in frequency and intensity. 15-20% weight loss. Hospitalization in Nov 2014 and Dec 2014. Xray and CT Scans identified SB dilation with possible SB obstruction.  Obstruction not responsive to medical therapies to include high dose prednisone.  March 2015 SB resection surgery, approx. 30 cm.
Age: 22.0
Sex: M
Vaccine: FLUN4
Symptoms: Intestinal dilatation, Laboratory test normal, Nausea, Pathology test, Respiratory tract congestion
Clinical narrative: Gradual onset of abdominal pain, nausea, vomiting and congestion.  Sept 2014 abdominal xrays (2) and ultrasound were normal. Labs normal. Symptoms progressed in frequency and intensity. 15-20% weight loss. Hospitalization in Nov 2014 and Dec 2014. Xray and CT Scans identified SB dilation with possible SB obstruction.  Obstruction not responsive to medical therapies to include high dose prednisone.  March 2015 SB resection surgery, approx. 30 cm.
Age: 22.0
Sex: M
Vaccine: FLUN4
Symptoms: Small intestinal obstruction, Small intestinal resection, Ultrasound scan normal, Vomiting, Weight decreased
Clinical narrative: Gradual onset of abdominal pain, nausea, vomiting and congestion.  Sept 2014 abdominal xrays (2) and ultrasound were normal. Labs normal. Symptoms progressed in frequency and intensity. 15-20% weight loss. Hospitalization in Nov 2014 and Dec 2014. Xray and CT Scans identified SB dilation with possible SB obstruction.  Obstruction not responsive to medical therapies to include high dose prednisone.  March 2015 SB resection surgery, approx. 30 cm.
Age: 22.0
Sex: M
Vaccine: FLUN4
Symptoms: X-ray abnormal
Clinical narrative: Gradual onset of abdominal pain, nausea, vomiting and congestion.  Sept 2014 abdominal xrays (2) and ultrasound were normal. Labs normal. Symptoms progressed in frequency and intensity. 15-20% weight loss. Hospitalization in Nov 2014 and Dec 2014. Xray and CT Scans identified SB dilation with possible SB obstruction.  Obstruction not responsive to medical therapies to include high dose prednisone.  March 2015 SB resection surgery, approx. 30 cm.
Age: 66.0
Sex: F
Vaccine: FLU3, PNC13
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Patient called pharmacy 6 weeks after receiving Flu and Prevnar13 shot stating that she has been having constant pain and not able move her left arm where she received the Prevnar13 vaccine. Patient states that she had tried several self treatment to help with the pain such Opiods, NSAIDs as well as applying Ice pack at the site of injection without relieve of the pain.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: VIIth nerve paralysis
Clinical narrative: The patient seemed to have come down with Bells Palsy as diagnosed by ER physicians. They stated that the Zostavax vaccine could have been the probable cause or link to the condition.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Chills, Musculoskeletal stiffness, Myalgia, Nasopharyngitis
Clinical narrative: Achy, shakes/shivering, nausea, muscle aches, joint aches, stiff neck, follwed the next day by severe cold type symptoms.
Age: 35.0
Sex: F
Vaccine: FLUX
Symptoms: Nausea, Pain, Tremor
Clinical narrative: Achy, shakes/shivering, nausea, muscle aches, joint aches, stiff neck, follwed the next day by severe cold type symptoms.
Age: 73.0
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Respiratory tract congestion
Clinical narrative: Fever, congestion. Patient went to walk-in clinic and they sent her straight to emergency room. Treated with unknown meds in ER, given Zpak and Albuterol rx.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Computerised tomogram head, Electrocardiogram, Endotracheal intubation, Fatigue, Gastrointestinal tube insertion
Clinical narrative: Initial symptoms include worsening fevers, fatigue, and muscle weakness that required hospitalization since 11/30/15. Currently still hospitalized at this time with pending inpatient rehab facility placement.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Gastrostomy, Muscular weakness, Nerve conduction studies, Nuclear magnetic resonance imaging, Pyrexia
Clinical narrative: Initial symptoms include worsening fevers, fatigue, and muscle weakness that required hospitalization since 11/30/15. Currently still hospitalized at this time with pending inpatient rehab facility placement.
Age: 77.0
Sex: F
Vaccine: PNC13
Symptoms: Chills, Injection site erythema, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Severe chills at bedtime 11/4, 100 fever on 11/5.  Injection site swollen, sore and red.  Slightly better 11/5 PM.  Swelling, soreness and redness spread about 3" down from injection site and lasted through week of 11/22/2015. Injection site lump slowly diminished over time but as of today 12/20/2015, I can still feel a small lump at injection site and when I shower, site area turns red.  Other than that, I am fine.
Age: 77.0
Sex: F
Vaccine: PNC13
Symptoms: Pyrexia
Clinical narrative: Severe chills at bedtime 11/4, 100 fever on 11/5.  Injection site swollen, sore and red.  Slightly better 11/5 PM.  Swelling, soreness and redness spread about 3" down from injection site and lasted through week of 11/22/2015. Injection site lump slowly diminished over time but as of today 12/20/2015, I can still feel a small lump at injection site and when I shower, site area turns red.  Other than that, I am fine.
Age: 73.0
Sex: F
Vaccine: PNC13
Symptoms: Injected limb mobility decreased, Injection site pain, Pain in extremity, Weight bearing difficulty
Clinical narrative: Pain radiating from site both up and down arm, limited range of motion, inability to pick up heavy objects reported by patient.  No treatment sought and it did not appear she would seek treatment.
Age: 75.0
Sex: M
Vaccine: PNC13
Symptoms: Arthralgia, Decreased appetite, Dizziness, Fatigue, Headache
Clinical narrative: Headache, muscle and joint pain, loss of appetite nausea, fatigue, dizziness.
Age: 75.0
Sex: M
Vaccine: PNC13
Symptoms: Myalgia, Nausea
Clinical narrative: Headache, muscle and joint pain, loss of appetite nausea, fatigue, dizziness.
Age: 68.0
Sex: M
Vaccine: FLU3, TDAP, VARZOS
Symptoms: Pain in extremity
Clinical narrative: Has been several weeks, over a month since patient received Zostavax vaccination. Patient reports prolonged arm soreness and has used tiger balm (OTC) to temporarily relieve the pain.
Age: 1.08
Sex: M
Vaccine: PNC13
Symptoms: Hypopnoea, Insomnia, Irritability, Palpitations, Pyrexia
Clinical narrative: Patient became crabby and possibly had a fever earlier in the day, perhaps 4pm however later in the day, around 10 PM, he seemed to have shallow breathing, heart racing, difficulty sleeping, hives all over and a fever.  Almost took him to the ER.  Around midnight I was able to settle him down with nursing, skin to skin contact.
Age: 1.08
Sex: M
Vaccine: PNC13
Symptoms: Urticaria
Clinical narrative: Patient became crabby and possibly had a fever earlier in the day, perhaps 4pm however later in the day, around 10 PM, he seemed to have shallow breathing, heart racing, difficulty sleeping, hives all over and a fever.  Almost took him to the ER.  Around midnight I was able to settle him down with nursing, skin to skin contact.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pruritus, Injection site rash, Injection site swelling, Urticaria, Vaccination site induration
Clinical narrative: On Friday afternoon patient noticed a rash developing on back right arm it was itchy and swollen. Patient also describes it as "hard" where vaccine was given on right side of face back hip. Patients hives have improved and rash on arm reducing and less swollen.
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Pt developed diffuse itchy hives across back and along arms. Recommended pt to use BENADRYL and seek emergency help if symptoms worsen.
Age: 56.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: 2nd year in a row pt. has a raised, irregular-shaped red area appear at injection site approx. 2 wks after inject. given. Will disappear in about 1-2 months. No pain, itching, or tenderness. Has no allergies to eggs or neomycin.
Age: 60.0
Sex: F
Vaccine: UNK
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Cellulitis -erythema, warmth, pain in upper arm around injection site.
Sex: F
Vaccine: HPV4
Symptoms: Adverse event
Clinical narrative: Information has been receive from a consumer via Corporate Twitter and an online article, referring to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL, (dose, lot# and route not reported). The article reported a mother claimed her daughter experienced horrendous adverse event which needed permanent care after receiving GARDASIL. The outcome of the event was unknown. The reporter considered the event to be disability. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with oral ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 12-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 18-NOV-2015 the patient was vaccinated with oral, ROTATEQ (lot # L008057, expiration date 01-DEC-2016, dose not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 09-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information had been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 25-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 03-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 69.0
Sex: F
Vaccine: PPV
Symptoms: Injection site pain, Pain, Pruritus generalised
Clinical narrative: Information has been received from a consumer referring to his 69 year old wife with iodine allergy. The patient's medical history included hormone replacement therapy. On 14-DEC-2015 the patient was vaccinated with PNEUMOVAX 23 (single 0.5 ml dose) intramuscularly. Concomitant therapy included unspecified hormone replacement therapy medication. On the same day, after receiving PNEUMOVAX 23, the patient experienced pain at the injection site and itching all over her body. She was also in pain. The patient sought medical attention via calling the physician's office. The patient used her personal unspecified prescription anti itch cream. Annual physical unspecified lab/diagnostic studies were performed (results unspecified). Therapy with PNEUMOVAX 23 was also reported as continued. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history of the patients were not reported. On unknown dates the patients vaccinated with improperly stored doses of oral, ROTATEQ (lot # K010325, expiry date 10-MAY-2016)(dose unspecified). Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 20-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 01-DEC-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 23-NOV-2015 the patient was vaccinated with ROTATEQ (lot # L008057, expiration date 01-DEC-2016, oral, dose not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 13-NOV-2015 the patient was vaccinated with oral, ROTATEQ (lot # L008057, expiration 01-DEC-2016, dose not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent conditions were not reported. On 24-NOV-2015 the patient was vaccinated with VAQTA (lot # L002717, expiration date 02-JUN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature (incorrect product storage). No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 30-NOV-2015 the patient was vaccinated with MMRII (lot # L001336, expiration date 13-JAN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 25-NOV-2015 the patient was vaccinated with MMRII (lot # L001336, expiration date 13-JAN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 18-NOV-2015 the patient was vaccinated with MMRII (lot # L001336, expiration date 13-JAN-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ orally (Lot# K016313 and expiration date 31-MAY-2016, strength and dose not reported). No symptoms had been reported. This one of two reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: HIBV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored PEDVAXHIB (Lot# K025002, expiration date 20-JUL-2017, strength, route and dose not reported). No symptoms had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (route, dose, lot # and expiration date not reported). No adverse effect had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. No pertinent or historical conditions were reported. On unknown dates, the patients were vaccinated with improperly stored ZOSTAVAX (route, dose, Lot# and expiration date not reported). No adverse effect had been reported. This is one of two reports received from the same reporter. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report as received from a physician's assistant refers to a patient of unknown age and gender. On 24-SEP-2015 the patient was vaccinated with an improperly stored dose of MMRII (lot # L003855 exp date 05-FEB-2017) (dose and route not reported). The temperature excursion was 53.8 F for 10.75 hours from 17-AUG-2015 to 06-NOV-2015. No adverse event was reported. This is one of several reports from the same source. Additional information is not expected as all follow up information to complete the case was received.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from a medical assistant and refers to an unknown number of patients of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unspecified dates, the patients were inadvertently vaccinated with GARDASIL (dose, route of administration, lot # and expiration date were not reported) that has been improperly stored. Concomitant therapy was not provided. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Retinopathy
Clinical narrative: Information has been received from a physician via a company representative referring to a female patient (reported as "the patient's wife") of unknown age. Concurrent conditions and medical history of the patient were not reported. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose and route unspecified). Two days after receiving ZOSTAVAX, the patient experienced retinopathy in an unspecified eye. The outcome of the event was unknown. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician assistant concerning a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were not provided. On unknown dates, the patient was vaccinated with 3 doses of VARIVAX (Merck) (lot numbers, expiration dates, dose and route unspecified) at another unspecified office. On an unspecified date after receiving the second of VARIVAX (Merck), the patient developed chickenpox. The patient's mother called to report this happened. However, the reporter had not seen the patient in the office yet so the chickenpox diagnosis hadn't been confirmed by reporter's office. The outcome of chickenpox was unknown. The causality was not provided. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: Information has been received from a Licensed Practical Nurse and a Registered Nurse referring to a patient of unknown age and gender. Concurrent conditions and medical history of the patient were not reported. On 02-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # K023328, expiry date 23-JUN-2016) (route and dose unspecified). Other suspect and concomitant therapies were not reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.